Join us on the latest episode! Our Guest: Samantha Dale Strasser, CEO & Co-Founder at Pepper Bio.
What you'll get out of this episode:
- Samantha Dale Strasser, co-founder and Chief Science Officer of Pepper Bio, shares her transition from academia to entrepreneurship, driven by a personal mission to change healthcare outcomes.
- Pepper Bio, located in Boston, leverages transomics to integrate multiple data sets for precision medicine, aiming to treat diseases that are currently untreatable.
- Strasser’s focus is on developing treatments for challenging diseases, with an emphasis on oncology, inflammatory diseases, and neurodegenerative disorders.
- Pepper Bio’s approach in drug discovery combines its own pipeline development with strategic partnerships, speeding up the process of bringing new treatments to the clinic.
- The company has made significant strides in identifying novel targets and shelved assets, leading to a high success rate in in vivo model validations.
To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/samantha-dale-strasser/
Company LinkedIn: https://www.linkedin.com/company/pepperbio/
Website: https://pepper.bio/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
